Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Persumac for CINV in Breast Cancer
NCT02787707Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Oct 2015
- Primary completion
- Apr 2016
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of Persumac in chemotherapy-induced nausea and vomiting (CINV), sponsored by Mashhad University of Medical Sciences. Started Oct 2015; status: completed.
02
Drugs
Persumac
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT02787707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02787707.